Angiotensin-converting enzyme and alpha-2-macroglobulin gene polymorphisms are not associated with Alzheimer's disease in Colombian patients
- 15 March 2004
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 218 (1-2), 47-51
- https://doi.org/10.1016/j.jns.2003.10.008
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits CytotoxicityJournal of Biological Chemistry, 2001
- The ACE gene and Alzheimer's disease susceptibilityJournal of Medical Genetics, 2000
- The deletion polymorphism and Val1000Ile in α-2-macroglobulin and Alzheimer disease in Caribbean HispanicsNeuroscience Letters, 2000
- Association between angiotensin-converting enzyme and Alzheimer disease.Archives of Neurology, 2000
- Alpha-2 macroglobulin gene in early- and late-onset Alzheimer diseaseNeuroscience Letters, 1999
- An α-2-macroglobulin insertion-deletion polymorphism in Alzheimer diseaseNature Genetics, 1999
- Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer diseaseNature Genetics, 1999
- Alpha-2 macroglobulin is genetically associated with Alzheimer diseaseNature Genetics, 1998
- α 2 -macroglobulin associates with β-amyloid peptide and prevents fibril formationProceedings of the National Academy of Sciences, 1998
- Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12Published by American Medical Association (AMA) ,1997